I would like to pay tribute to Andy. It was two years ago that he suddenly passed away. When I called, he always had time for me. Please join me in a special prayer/tribute to our founder. After all, that's why we're here.
Blessings, Andy.
Andrew J. Whelan, founder, and CEO of BioElectronics Corp. suddenly passed away in his home Monday night in Frederick, Maryland. Mr. Whelan founded BioElectronics Corporation to bring to market a breakthrough drug-free medical device, ActiPatch Therapy. ActiPatch is an analgesic device that also reduces inflammation and speeds healing.
Since its founding, Whelan successfully earned several Food & Drug Administration clearances and medical device approvals around the world. Under Whelan’s leadership, the Company earned FDA approval for reduction of edema following blepharoplasty, for osteoarthritis of the knee, and for relief of plantar fasciitis. Most recently it has won approval on the use of ActiPatch for post-operative pain to mitigate opioid use and has submitted an FDA 510(k) application for market clearance for the broad treatment of musculoskeletal pain. BioElectronics products have won multiple awards.
Andrew J. Whelan Biography
Mr. Whelan served as the President from April 2000 – 2005. He was a seasoned business executive with a strong financial, consulting and management background. From 1993 to April 2000, Mr. Whelan served as the President of P.A. Whelan & Company, Inc., a consulting firm owned by Mr. Whelan and his wife that specialized in the health care industry. Mr. Whelan was also a founder of Drug Counters, Inc., a chain of managed care retail pharmacies, where he served as President and Chief Executive Officer from 1992 until 1993. Drug Counters was sold to Diagnostek, Inc. in 1994. From 1984 until 1992, Mr. Whelan served as Chairman of the Board of Directors and President of Physicians’ Pharmaceutical Services, Inc., a public company of which he was a founder.
BUY $BIEL$
